[Goose]

Relax, on the very day that the MTL-backed announcement came out, another AI enabled drug developer, benevolent AI, announced it was cutting 30% of its staff and closing a site in the US: https://www.fiercebiotech.com/biotech/be...-gap-looms

(speaking for myself, and not my employer here) AI is a tool, nothing more and nothing less.  It has the promise of making drug development more efficient, as right now about 1 in 20 drugs that makes it into clinical trials winds up being approved.  But the hype has gotten way ahead of the results, and my guess is that while the industry will get better at incorporating AI into workflows and AI can help improve success rates, we are not going to have robot overlords creating a humanity-killing scenario.

BC

For what little it is worth, I agree with you. Precision Drug Discovery was the first wave of how computers were going to "revolutionize" the industry. It didn't. After that, it was High Throughput Screening. Similar outcome. AI IMO will be similar. All these are important tools but none of them are by themselves "game changers".  The only "winners" were the VCs who rode the hype to outlandish valuations.

Also, I doubt MTL is going to spend a lot of time directly supervising research. He will have bigger fish to fry. It is also difficult to falsify results in industry. At the end of the day the FDA will demand efficacy and safety demonstrated in clinical trials. There is QA and GMP all over the place.

[Goose]

Relax, on the very day that the MTL-backed announcement came out, another AI enabled drug developer, benevolent AI, announced it was cutting 30% of its staff and closing a site in the US: https://www.fiercebiotech.com/biotech/be...-gap-looms

(speaking for myself, and not my employer here) AI is a tool, nothing more and nothing less.  It has the promise of making drug development more efficient, as right now about 1 in 20 drugs that makes it into clinical trials winds up being approved.  But the hype has gotten way ahead of the results, and my guess is that while the industry will get better at incorporating AI into workflows and AI can help improve success rates, we are not going to have robot overlords creating a humanity-killing scenario.

BC

For what little it is worth, I agree with you. Precision Drug Discovery was the first wave of how computers were going to "revolutionize" the industry. It didn't. After that, it was High Throughput Screening. Similar outcome. AI IMO will be similar. All these are important tools but none of them are by themselves "game changers".  The only "winners" were the VCs who rode the hype to outlandish valuations.

Also, I doubt MTL is going to spend a lot of time directly supervising research. He will have bigger fish to fry. It is also difficult to falsify results in industry. At the end of the day the FDA will demand efficacy and safety demonstrated in clinical trials. There is QA and GMP all over the place.